The effect of PPARgamma stimulation on glucose metabolism, insulin resistance, growth hormone and cortisol on women suffering from polycystic ovary syndrome

Trial Profile

The effect of PPARgamma stimulation on glucose metabolism, insulin resistance, growth hormone and cortisol on women suffering from polycystic ovary syndrome

Completed
Phase of Trial: Phase IV

Latest Information Update: 26 Nov 2012

At a glance

  • Drugs Pioglitazone (Primary)
  • Indications Polycystic ovary syndrome
  • Focus Biomarker; Pharmacodynamics
  • Most Recent Events

    • 01 Mar 2009 Results from an analysis of secondary endpoints published in Fertility and Sterility.
    • 01 Sep 2008 Results published in the Journal of Clinical Endocrinology and Metabolism.
    • 01 May 2008 Results have been reported.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top